These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6322295)

  • 21. Structure and biosynthesis of pro-adrenocorticotropin/endorphin and related peptides.
    Eipper BA; Mains RE
    Endocr Rev; 1980; 1(1):1-27. PubMed ID: 6262069
    [No Abstract]   [Full Text] [Related]  

  • 22. Proton NMR and CD solution conformation determination and opioid receptor binding studies of a dynorphin A(1-17) model peptide.
    Vaughn JB; Taylor JW
    Biochim Biophys Acta; 1989 Nov; 999(2):135-46. PubMed ID: 2574597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and biological activity of peptides which release growth hormone in vitro.
    Momany FA; Bowers CY; Reynolds GA; Chang D; Hong A; Newlander K
    Endocrinology; 1981 Jan; 108(1):31-9. PubMed ID: 6109621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discordances in the temporal pattern of the ACTH/beta-endorphin releasing effects of synthetic CRFs and partially purified bovine CRF in a superfusion system.
    Yasuda Y; Yasuda N
    Horm Metab Res; 1986 May; 18(5):313-7. PubMed ID: 3013743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrophobic interactions and the design of receptor mimetic peptides.
    Martin-Moe SA; Lehr R; Cauley MD; Moe GR
    Pept Res; 1995; 8(2):70-6. PubMed ID: 7544657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An optimized solid phase synthesis strategy--including on-resin lactamization--of astressin, its retro-, inverso-, and retro-inverso isomers as corticotropin releasing factor antagonists.
    Rijkers DT; den Hartog JA; Liskamp RM
    Biopolymers; 2002 Feb; 63(2):141-9. PubMed ID: 11787002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amphiphilic cationic peptides mediate cell adhesion to plastic surfaces.
    Rideout DC; Lambert M; Kendall DA; Moe GR; Osterman DG; Tao HP; Weinstein IB; Kaiser ET
    J Cell Physiol; 1985 Sep; 124(3):365-71. PubMed ID: 4044659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemistry of beta-endorphin.
    Li CH
    Adv Biochem Psychopharmacol; 1979; 20():145-63. PubMed ID: 382769
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on peptides. CXXIII. Preparations of nine peptide fragments for the synthesis of human corticotropin releasing factor (hCRF).
    Fujii N; Nomizu M; Akaji K; Shimokura M; Katakura S; Yajima H
    Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4786-96. PubMed ID: 6335979
    [No Abstract]   [Full Text] [Related]  

  • 30. Binding of hormones and neuropeptides by calmodulin.
    Malencik DA; Anderson SR
    Biochemistry; 1983 Apr; 22(8):1995-2001. PubMed ID: 6189515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of the luteinizing releasing hormone of the hypothalamus and its hormonal activity.
    Sievertsson H; Chang JK; Bogentoft C; Currie BL; Folkers K
    Biochem Biophys Res Commun; 1971 Sep; 44(6):1566-71. PubMed ID: 4946265
    [No Abstract]   [Full Text] [Related]  

  • 32. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.
    Seebach D; Beck AK; Bierbaum DJ
    Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple stimulation of the adenohypophysis by combinations of hypothalamic releasing factors.
    Wehrenberg WB; Baird A; Ying SY; Rivier C; Ling N; Guillemin R
    Endocrinology; 1984 Jun; 114(6):1995-2001. PubMed ID: 6327231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent morphiceptin analogs: structure activity relationships and morphine-like activities.
    Chang KJ; Wei ET; Killian A; Chang JK
    J Pharmacol Exp Ther; 1983 Nov; 227(2):403-8. PubMed ID: 6313901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Endorphins: structure, roles and biogenesis].
    Chrétien M; Seidah NG; Scherrer H
    Can J Physiol Pharmacol; 1981 May; 59(5):413-31. PubMed ID: 6263434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells.
    Vale W; Vaughan J; Smith M; Yamamoto G; Rivier J; Rivier C
    Endocrinology; 1983 Sep; 113(3):1121-31. PubMed ID: 6307665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of an amphiphilic helical structure in beta-endorphin through the design, synthesis, and study of model peptides.
    Taylor JW; Miller RJ; Kaiser ET
    J Biol Chem; 1983 Apr; 258(7):4464-71. PubMed ID: 6300088
    [No Abstract]   [Full Text] [Related]  

  • 38. Secondary structure prediction of sauvagine, a novel biologically active polypeptide from a frog.
    Montecucchi PC; Gozzini L
    Int J Pept Protein Res; 1982 Aug; 20(2):139-43. PubMed ID: 6981615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and characterization of a model peptide having potent calcitonin-like biological activity: implications for calcitonin structure/activity.
    Moe GR; Kaiser ET
    Biochemistry; 1985 Apr; 24(8):1971-6. PubMed ID: 2990546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The conformation, flexibility, and dynamics of polypeptide hormones.
    Blundell T; Wood S
    Annu Rev Biochem; 1982; 51():123-54. PubMed ID: 6126154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.